You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker
- 2. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 3. Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis
- 4. Aspirin a day keeps bowel cancer at bay
- 5. Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them
- 6. Top biotech deals in June 2025
- 7. Expression of Insulin-like growth factor 2 mRNA-binding protein 3 and its diagnostic value in breast cancer
- 8. Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
- 9. The fatal mutation that lets cancer outsmart the human immune system
- 10. Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Last updated at 9:47 GMT
Hot News Makers
Health/Pharma Companies
- 153592.85
- 30280.58
- 27026.68
- 20720.62
- 16925.06
- 12285.92
- 10761.90
- 6332.05
- 4338.62
- 3234.04
Drugs, Treatments, Trials
- 185678.47
- 14033.33
- 13756.54
- 8445.42
- 8389.38
- 7211.74
- 6392.31
- 2576.67
- 1850.52
- 1480.41
Last updated at 9:10 GMT
